Original Article
Title: COVID-19 symptoms are attenuated in atopic dermatitis patients treated with dupilumab
Short running title: Reduced COVID-19 symptoms in dupilumab-treated AD
Authors: Benjamin Ungar, MD1; Jacob W. Glickman, MD1*; Alexandra Golant, MD1*; Celina Dubin, BA1; Olga Marushchak, MA1,2; Alyssa Gontzes, BS1; Daniela Mikhaylov, BA1; Giselle K. Singer, BS1; Danielle Baum, RN1; Nancy Wei, BA1; Diana Gruenstein, BA1; Mark G. Lebwohl, MD1; Ana B. Pavel, PhD1,3; Emma Guttman-Yassky, MD, PhD1
  1. Department of Dermatology and Laboratory of Inflammatory Skin Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  2. Touro College of Osteopathic Medicine, New York, NY, USA
  3. Department of Biomedical Engineering, The University of Mississippi, University, MS, USA
*Authors contributed equally